NALOXONE

0.4 Micromol Solution for Inj/Inf

Orpha-Devel Handels und Vertriebs GmbHPA1353/003/001

SPC: MARKETING AUTHORISATION NUMBER

18 May 2015 - 15 Jun 201715 Jun 2017 - Present
PA1353/003/001

PA1353/003/001
« Back

Latest Changes to Medicine Info & SPC


Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.